Literature DB >> 26783073

The Effects of Continuous In Vivo Administration of Nisin on Staphylococcus aureus Infection and Immune Response in Mice.

A M Brand1, C Smith2, L M T Dicks3,4.   

Abstract

Mice were intraperitoneally infected with 2 × 10(8) cfu Staphylococcus aureus Xen 36 and treated with 2,130 AU (arbitrary units) nisin (equivalent to 27.7 μg pure nisin), a class Ia lantibiotic, over 7 days. The metabolic activity of S. aureus Xen 36, concluded from changes in cell bioluminescence, declined for the first 3.5 h, but increased over the next 24 h and remained at this level for the remainder of the 7-day trial. Similar results were obtained with heat-inactivated (25 min at 121 °C) nisin, suggesting that the decline in metabolic activity of S. aureus Xen 36 cannot be attributed to the bacteriostatic activity of nisin. The decline in lymphocyte numbers in infected mice was of smaller magnitude after treatment with active nisin compared to inactive nisin, suggesting that active nisin limited the apoptosis of lymphocytes. The drastic increase in neutrophil versus lymphocyte (N:L) ratio observed in the presence of active nisin suggested that the decline in metabolic activity of S. aureus Xen 36 was due to an immune response triggered by the infection. Nisin, active or inactive, stimulated the activity of cytokines interleukin-6, interleukin-10 and tumour necrosis factor. However, the overall immune response triggered by both forms of nisin was too minute to trigger an abnormally high antigenic immune reaction.

Entities:  

Keywords:  Bioluminescence; Immune response; Staphylococcus aureus

Year:  2013        PMID: 26783073     DOI: 10.1007/s12602-013-9141-3

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  19 in total

1.  To protect peptide pharmaceuticals against peptidases.

Authors:  R Rink; A Arkema-Meter; I Baudoin; E Post; A Kuipers; S A Nelemans; M Haas Jimoh Akanbi; G N Moll
Journal:  J Pharmacol Toxicol Methods       Date:  2010-02-20       Impact factor: 1.950

2.  Enhanced nisin production by increasing genes involved in nisin Z biosynthesis in Lactococcus lactis subsp. lactis A164.

Authors:  Chan-Ick Cheigh; Hoon Park; Hak-Jong Choi; Yu-Ryang Pyun
Journal:  Biotechnol Lett       Date:  2005-02       Impact factor: 2.461

Review 3.  Lipid II as a target for antibiotics.

Authors:  Eefjan Breukink; Ben de Kruijff
Journal:  Nat Rev Drug Discov       Date:  2006-04       Impact factor: 84.694

4.  Manipulation of innate immunity by a bacterial secreted peptide: lantibiotic nisin Z is selectively immunomodulatory.

Authors:  Jason Kindrachuk; Håvard Jenssen; Melissa Elliott; Anastasia Nijnik; Laure Magrangeas-Janot; Mukesh Pasupuleti; Lisa Thorson; Shuhua Ma; Donna M Easton; Manjeet Bains; Brett Finlay; Eefjan J Breukink; Hans Georg-Sahl; Robert E W Hancock
Journal:  Innate Immun       Date:  2012-10-29       Impact factor: 2.680

5.  Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo.

Authors:  A D van Staden; A M Brand; L M T Dicks
Journal:  J Appl Microbiol       Date:  2012-02-13       Impact factor: 3.772

6.  Evaluation of Nisin F in the Treatment of Subcutaneous Skin Infections, as Monitored by Using a Bioluminescent Strain of Staphylococcus aureus.

Authors:  M de Kwaadsteniet; C A van Reenen; L M T Dicks
Journal:  Probiotics Antimicrob Proteins       Date:  2009-08-13       Impact factor: 4.609

Review 7.  Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update.

Authors:  Jean Guy LeBlanc; Camille Aubry; Naima G Cortes-Perez; Alejandra de Moreno de LeBlanc; Nathalie Vergnolle; Philippe Langella; Vasco Azevedo; Jean-Marc Chatel; Anderson Miyoshi; Luis G Bermúdez-Humarán
Journal:  FEMS Microbiol Lett       Date:  2013-05-16       Impact factor: 2.742

8.  Characterization of the structural gene encoding nisin F, a new lantibiotic produced by a Lactococcus lactis subsp. lactis isolate from freshwater catfish (Clarias gariepinus).

Authors:  M de Kwaadsteniet; K Ten Doeschate; L M T Dicks
Journal:  Appl Environ Microbiol       Date:  2007-11-26       Impact factor: 4.792

9.  Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus.

Authors:  M De Kwaadsteniet; K T Doeschate; L M T Dicks
Journal:  Lett Appl Microbiol       Date:  2008-11-14       Impact factor: 2.858

10.  Immunomodulatory effects of nisin in turbot (Scophthalmus maximus L.).

Authors:  L Villamil; A Figueras; B Novoa
Journal:  Fish Shellfish Immunol       Date:  2003-02       Impact factor: 4.581

View more
  2 in total

1.  In vitro and In vivo Antibacterial Effects of Nisin Against Streptococcus suis.

Authors:  Haodan Zhu; Lixiao Han; Yanxiu Ni; Zhengyu Yu; Dandan Wang; Junming Zhou; Bin Li; Wei Zhang; Kongwang He
Journal:  Probiotics Antimicrob Proteins       Date:  2021-01-06       Impact factor: 4.609

Review 2.  Probiotics at War Against Viruses: What Is Missing From the Picture?

Authors:  Santosh Kumar Tiwari; Leon M T Dicks; Igor V Popov; Alena Karaseva; Alexey M Ermakov; Alexander Suvorov; John R Tagg; Richard Weeks; Michael L Chikindas
Journal:  Front Microbiol       Date:  2020-08-20       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.